Skip to content

Pregnancy rate among HIV-positive women in the UK has increased significantly

HIV prevalence beginning to fall in South African children

Treatment with a ritonavir-boosted protease inhibitor during pregnancy increases risk of preterm delivery

Tenofovir use during pregnancy doesn't affect infant size or weight at birth, but may by one year of age

Kenya: Only 4% of pregnant women started ART within 6 months of diagnosis

Keeping mothers in care: the real-world challenge for PMTCT programmes

UK guidelines on treatment of HIV in pregnancy give green light to efavirenz

Use of some anti-HIV drugs during pregnancy linked to cleft lip and palate; investigators urge cautious interpretation of results

Can speeding up nevirapine clearance reduce the risk of resistance after PMTCT use?